9 Meters Biopharma Inc
(NMTR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 46,993 | 53,609 | 64,024 | 38,496 | 37,851 |
| Other current assets | 0 | 0 | 75 | 75 | 75 |
| TOTAL | $49,985 | $56,479 | $65,783 | $39,984 | $38,927 |
| Non-Current Assets | |||||
| PPE Net | 16 | 16 | 15 | 15 | 11 |
| Other Non-Current Assets | 172 | 185 | 197 | 209 | 220 |
| TOTAL | $188 | $201 | $212 | $224 | $232 |
| Total Assets | $50,174 | $56,680 | $65,994 | $40,208 | $39,159 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,435 | 1,316 | 1,636 | 1,371 | 1,488 |
| Accrued Expenses | 5,968 | 5,912 | 5,028 | 4,566 | 5,290 |
| Other current liabilities | N/A | N/A | N/A | N/A | 7 |
| TOTAL | $8,457 | $7,281 | $6,715 | $5,987 | $6,849 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 113 | 128 | 141 | 155 | 168 |
| TOTAL | $113 | $128 | $141 | $155 | $168 |
| Total Liabilities | $8,570 | $7,409 | $6,857 | $6,142 | $7,016 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 12,912 | 12,783 | 12,738 | 12,569 | 10,804 |
| Common Shares | 1 | 26 | 25 | 22 | 21 |
| Retained earnings | -168,841 | -159,286 | -145,746 | -137,492 | -132,061 |
| TOTAL | $41,603 | $49,271 | $59,138 | $34,066 | $32,142 |
| Total Liabilities And Equity | $50,174 | $56,680 | $65,994 | $40,208 | $39,159 |